- Home
- NHTC vs CUE Comparison
NHTC vs CUE Comparison
Compare NHTC & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHTC
- CUE
- Stock Information
- Founded
- NHTC 1988
- CUE 2014
- Country
- NHTC United States
- CUE United States
- Employees
- NHTC N/A
- CUE N/A
- Industry
- NHTC Diversified Commercial Services
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- NHTC Miscellaneous
- CUE Health Care
- Exchange
- NHTC Nasdaq
- CUE Nasdaq
- Market Cap
- NHTC 56.0M
- CUE 61.1M
- IPO Year
- NHTC 1995
- CUE 2018
- Fundamental
- Price
- NHTC $4.43
- CUE $0.82
- Analyst Decision
- NHTC
- CUE Strong Buy
- Analyst Count
- NHTC 0
- CUE 2
- Target Price
- NHTC N/A
- CUE $3.00
- AVG Volume (30 Days)
- NHTC 30.8K
- CUE 288.5K
- Earning Date
- NHTC 10-29-2025
- CUE 11-13-2025
- Dividend Yield
- NHTC 18.06%
- CUE N/A
- EPS Growth
- NHTC N/A
- CUE N/A
- EPS
- NHTC 0.03
- CUE N/A
- Revenue
- NHTC $42,087,000.00
- CUE $8,286,000.00
- Revenue This Year
- NHTC N/A
- CUE N/A
- Revenue Next Year
- NHTC N/A
- CUE N/A
- P/E Ratio
- NHTC $149.67
- CUE N/A
- Revenue Growth
- NHTC N/A
- CUE N/A
- 52 Week Low
- NHTC $4.02
- CUE $0.54
- 52 Week High
- NHTC $6.79
- CUE $1.99
- Technical
- Relative Strength Index (RSI)
- NHTC 49.01
- CUE 58.11
- Support Level
- NHTC $4.30
- CUE $0.76
- Resistance Level
- NHTC $4.68
- CUE $0.84
- Average True Range (ATR)
- NHTC 0.20
- CUE 0.06
- MACD
- NHTC 0.01
- CUE 0.01
- Stochastic Oscillator
- NHTC 42.21
- CUE 49.98
About NHTC Natural Health Trends Corp.
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.